No description available.

No description available.

Myosin 1c (Myo1c) is a molecular motor involved in regulation of tension-gated ion channels, exocytosis, endocytosis, motility and other membrane-related events. Moreover, it acts as a dynamic linker between the cell membrane and cortical actin network, contributing to the maintenance of plasma membrane tension. In contrast, nuclear myosin 1 (NM1), an isoform of Myo1c, has been described only in the nucleus where it participates in various nuclear processes, including transcription or chromatin remodeling. However, although traditionally regarded as exclusively cytoplasmic or nuclear, all myosin 1c isoforms participate in nuclear functions and they are present in the cytoplasm as well. The main focus of this study was to characterize the functional significance of NM1 in the cytoplasm. We have found that NM1 localizes to plasma membrane and shows a uniform punctuated distribution with a high concentration at the cell periphery. Moreover, atomic force microscopy measurements of mouse NM1 KO fibroblasts revealed a significant increase in an overall plasma membrane elasticity in comparison to WT cells, indicating a disruption in the regulation of plasma membrane tension caused by the loss of NM1. Since a higher membrane elasticity and deformability is a characteristic marker of cancer cells,...

No description available.

La myosine est une protéine motrice impliquée dans la contraction du muscle lisse. Un de ces isoformes, appelé (+)insert lui procure une vélocité accrue. L’objectif de cette étude était d’évaluer la contribution de cet isoforme au bronchospasme observé chez les chevaux atteints de souffle, un modèle d’asthme humain. Nous avons procédé à l’analyse de l’expression génique de l’isoforme (+)insert dans les voies respiratoires de chevaux issus de 3 cohortes afin d’évaluer 1) la présence de cet isoforme chez les chevaux atteints de souffle ; 2) la réversibilité de son expression avec 2 traitements usuels (corticostéroïdes inhalés et retrait antigénique); et 3) la cinétique de réapparition de l’isoforme suite à une période de rémission de la maladie. Les résultats révèlent 1) une expression augmentée de l’isoforme (+)insert dans l’ensemble de l’arbre bronchique des chevaux atteints de souffle en exacerbation comparée aux contrôles et aux chevaux en rémission ; 2) les deux traitements conduisent à une réduction de l’expression de l’isoforme, mais l’administration de corticostéroïdes mène à une diminution plus rapide que celle induite par le retrait antigénique; et 3) une période de 30 jours ou plus d'exposition antigénique est nécessaire pour la réapparition de l’isoforme (+)insert dans l’arbre bronchique des chevaux atteints de souffle. Cette étude montre pour la première fois une modulation et une réversibilité de l’expression de l'isoforme (+)insert de la myosine en fonction du statut médical du sujet. Les données suggèrent que cet isoforme pourrait faire partie d’un mécanisme protecteur activé en réponse à une exposition antigénique prolongée. / Myosin is a motor protein implicated in smooth muscle contraction. The (+)insert isoform doubles smooth muscle velocity. The aim of the study was to evaluate the contribution of the fast contracting myosin isoform to bronchospasm in heaves-affected horses as model of human asthma. Gene expression analysis of the (+)insert myosin isoform in equine airways was performed in three different cohorts to evaluate 1) its presence and anatomical location in heaves-affected horses; 2) the reversibility of its expression with two common therapies (inhaled corticosteroids and antigen avoidance); and 3) its kinetics of reappearance following a chronic antigen exposure. Results showed 1) a significantly increased expression of the (+)insert isoform at all levels of the bronchial tree of horses with heaves in clinical exacerbation when compared to control horses and heaves-affected horses in clinical remission; 2) both treatments reduced the fast isoform expression in horses’ lower airways, but the administration of corticosteroids led to a faster response; and 3) (+)insert isoform does not increase in airways of all horses with heaves within 30 days of antigen exposure. The study shows for the first time a modulation of the fast contracting myosin isoform with the disease status. Data also suggest that (+)insert isoform is part of a protective mechanism enhanced in response to a prolonged antigen exposure.

La myosine est une protéine motrice impliquée dans la contraction du muscle lisse. Un de ces isoformes, appelé (+)insert lui procure une vélocité accrue. L’objectif de cette étude était d’évaluer la contribution de cet isoforme au bronchospasme observé chez les chevaux atteints de souffle, un modèle d’asthme humain. Nous avons procédé à l’analyse de l’expression génique de l’isoforme (+)insert dans les voies respiratoires de chevaux issus de 3 cohortes afin d’évaluer 1) la présence de cet isoforme chez les chevaux atteints de souffle ; 2) la réversibilité de son expression avec 2 traitements usuels (corticostéroïdes inhalés et retrait antigénique); et 3) la cinétique de réapparition de l’isoforme suite à une période de rémission de la maladie. Les résultats révèlent 1) une expression augmentée de l’isoforme (+)insert dans l’ensemble de l’arbre bronchique des chevaux atteints de souffle en exacerbation comparée aux contrôles et aux chevaux en rémission ; 2) les deux traitements conduisent à une réduction de l’expression de l’isoforme, mais l’administration de corticostéroïdes mène à une diminution plus rapide que celle induite par le retrait antigénique; et 3) une période de 30 jours ou plus d'exposition antigénique est nécessaire pour la réapparition de l’isoforme (+)insert dans l’arbre bronchique des chevaux atteints de souffle. Cette étude montre pour la première fois une modulation et une réversibilité de l’expression de l'isoforme (+)insert de la myosine en fonction du statut médical du sujet. Les données suggèrent que cet isoforme pourrait faire partie d’un mécanisme protecteur activé en réponse à une exposition antigénique prolongée. / Myosin is a motor protein implicated in smooth muscle contraction. The (+)insert isoform doubles smooth muscle velocity. The aim of the study was to evaluate the contribution of the fast contracting myosin isoform to bronchospasm in heaves-affected horses as model of human asthma. Gene expression analysis of the (+)insert myosin isoform in equine airways was performed in three different cohorts to evaluate 1) its presence and anatomical location in heaves-affected horses; 2) the reversibility of its expression with two common therapies (inhaled corticosteroids and antigen avoidance); and 3) its kinetics of reappearance following a chronic antigen exposure. Results showed 1) a significantly increased expression of the (+)insert isoform at all levels of the bronchial tree of horses with heaves in clinical exacerbation when compared to control horses and heaves-affected horses in clinical remission; 2) both treatments reduced the fast isoform expression in horses’ lower airways, but the administration of corticosteroids led to a faster response; and 3) (+)insert isoform does not increase in airways of all horses with heaves within 30 days of antigen exposure. The study shows for the first time a modulation of the fast contracting myosin isoform with the disease status. Data also suggest that (+)insert isoform is part of a protective mechanism enhanced in response to a prolonged antigen exposure.

Muscle mechanical behavior potentially plays an important role in some of the most common bladder disorders. These include overactive bladder, which can involve involuntary contractions during bladder filling, and impaired contractility or underactive bladder, which may involve weak or incomplete contractions during voiding. Actin-myosin cross-bridges in detrusor smooth muscle (DSM) are responsible for contracting and emptying the bladder. The total tension produced by muscle is the sum of its preload and active tensions. Studies suggest that actin-myosin cross-links are involved in adjustable preload stiffness (APS), which is characterized by a preload tension curve that can be shifted along the length axis as a function of strain history and activation history. DSM also exhibits length adaptation in which the active tension curve can exhibit a similar shift. Actin-myosin cross-bridges are also responsible for myogenic contractions in response to quick stretch of DSM strips and spontaneous rhythmic contractions (SRC) that may occur during bladder filling. Studies show that SRC may participate in the mechanical regulation of both APS and length adaptation. However, the mechanical mechanisms by which actin-myosin interactions enable this interrelated combination of behaviors remain to be determined and were the primary focus of this dissertation. The objectives of this study were to: 1) provide evidence to support the hypothesis that a common mechanism is responsible for SRC and myogenic contraction, 2) develop a sensor-based mechanical model to demonstrate that SRC in one cell is sufficient to trigger stretch-induced myogenic contraction in surrounding cells and propagate the contraction, and 3) develop a conceptual model with actin-myosin cross-bridges and cross-links that produces the coupled mechanical behaviors of APS, SRC, and length adaptation in DSM. Improved understanding of bladder biomechanics may enable the identification of specific targets for the development of new treatments for overactive and underactive bladder.

The longitudinal muscle layer in gut is the functional opponent to the circular muscle layer during the peristalsis reflex. Differences in innervation of the layers allow for the contraction of one layer that corresponds with the simultaneous relaxation of the other, enabling the passage of gut contents in a controlled fashion. Differences in development have given the cells of the two layers differences in receptor populations, membrane lipid handling, and calcium handling profiles/behaviors. The kinase signaling differences between the two layers is not as well characterized. Upon activation of cells from the circular muscle layer, it is known that Rho kinase and ERK1/2 promote contraction, while CaMKK/AMPK and CaMKII perform inhibitory/self-inhibitory roles. Such behaviors are poorly understood in the longitudinal muscle layer. In longitudinal muscle strips, we measured muscarinic receptor-mediated contraction following incubation with kinase inhibitors. Upon comparison to control, contributions of Rho Kinase and ERK1/2 were similar to those seen in circular muscle. Inhibition of both of these enzymes leads to diminished contraction. However, CaMKK/AMPK and CaMKII have effects in longitudinal muscle opposite to their regulation in circular muscle – their inhibition also diminishes the contractile response. These contractile data from strips were supported by immunokinase assay measurements of MLCK activity from strip homogenates with and without kinase inhibition. Therefore, we suggest that the activities of CaMKK/AMPK and CaMKII in longitudinal muscle are indeed different from their regulatory roles in circular muscle, perhaps a consequence of the different calcium handling modalities of the two muscle types.

La vie repose sur des conversions d’énergie libre assurées par des machines moléculaires. Parmi elles, la myosine couple l’hydrolyse de l’ATP à la production de force sur l’actine par basculement d’un « bras de levier ». Compléter le cycle requiert une étape de régénération, ou recovery stroke, où le moteur retourne dans sa configuration armée et hydrolyse l’ATP. Comprendre ce couplage chimio-mécanique est critique pour révéler les principes de fonctionnement des moteurs moléculaires. Cette thèse aborde la question via des simulations moléculaires. Partant d’une nouvelle structure cristallographique de la myosine VI, nous proposons un mécanisme original pour le recovery stroke dans lequel la remise en place du bras de levier est déclenchée par les fluctuations thermiques et précède la fermeture du site actif, au contraire des modèles précédemment acceptés. / Life relies on free energy conversions performed by molecular machines. Among them, myosin couples the hydrolysis of ATP to force production on actin through a swing of a « lever-arm ». Completing the cycle requires a regeneration step, the recovery stroke, in which the motor returns to its armed configuration and hydrolyzes ATP. Understanding this chemo-mechanical coupling is critical to unravel the functioning principles of molecular motors. In this thesis, we tackle the problem using molecular simulations. Capitalizing on a new crystal structure of myosin VI, we propose an original mechanism for the recovery stroke in which the re-priming of the lever arm is driven by thermal fluctuations and precedes the closure of the active site, unlike previously accepted models.

Avaliamos os efeitos da glicação do colágeno (CG) e da glicose elevada sobre a migração de fibroblastos. Utilizamos células de ratos controle e diabéticos (D) e células NIH-3T3, cultivadas em glicose 5 mM ou 30 mM (HG). Para glicação utilizou-se ácido glioxílico. O CG apresentou menor resistência à tração e elasticidade. Fibroblastos migraram menos sob HG e sobre o CG. As células D no CG não se deslocaram, apresentaram menos integrina β141 e expressaram mais α-actina de músculo liso. A viscoelasticidade do citoesqueleto foi menor em células D, especialmente sobre o CG. Sobre fibronectina, células NIH-3T3 em HG apresentaram menos fibras de estresse e deficiência na retração da parte traseira. A expressão de miosinas IIA (MIIA), IIB (MIIB) e MRLC não foi alterada, mas a fosforilação de MII diminuiu. A distribuição de MIIB ficou mais difusa, enquanto MIIA não mudou. Células HG exerceram menor força sobre o substrato. A migração de fibroblastos em ambiente hiperglicêmico é deficiente, especialmente frente ao CG, em parte devido a uma redução da contratilidade celular. / We evaluated the effects of collagen glycation (GC) and high glucose concentrations on fibroblasts migration. Fibroblasts derived from control and diabetic rats (D) and NIH-3T3 cells were cultured under 5 mM or 30 mM glucose (HG). For glycation, glyoxylic acid was used. The GC showed lower tensile strength and elasticity. Fibroblasts migrated less in HG and over the GC. D cells did not move on GC, showed less β141 integrin and a higher expression of smooth muscle α-actin. The viscoelasticity of the cytoskeleton was lower in D cells, especially on the GC. On fibronectin, NIH-3T3 cells under HG had fewer stress fibers and showed impaired contraction at the rear, presenting long tails. The expression of myosin IIA (MIIA), IIB (MIIB) and MRLC has not changed, but the phosphorylation of MII decreased. The distribution of MIIB became more diffuse, while MIIA has not changed. Cells under HG exerted less force on the substrate. The migration of fibroblasts in hyperglycemic environment is impaired, especially on GC, partly due to a reduction of cell contractility.